Triple-Agonist Research Peptide

ProPeptide Retatrutide 40mg Vial

Name: ProPeptide Retatrutide 40mg
Brand: ProPeptide
SKU: PP-RETA-40MG
Availability: InStock

GLP-1 + GIP + Glucagon — 40mg Lyophilized Research Format

Retatrutide (LY3437943) is a synthetic triple-agonist research peptide developed by Eli Lilly that simultaneously activates GLP-1, GIP, and glucagon receptors. The 40mg lyophilized vial format is intended for laboratory research workflows that require custom reconstitution. Cold-chain delivered across the UAE.

40mg lyophilized LY3437943 Cold-chain dispatch Same-day Dubai delivery

Order Now → View FAQ

ProPeptide · UAE Stock

Research Only

ProPeptide Retatrutide 40mg

Retatrutide 40mg Vial

Triple-agonist research peptide — GLP-1 satiety + GIP insulin + Glucagon expenditure. Lyophilized format, cold-chain delivered. Dubai stock.

Compound

Retatrutide
CAS 2381089-83-2

Brand

ProPeptide
UAE stock

Format

Lyophilized vial
40mg · reconstitute

Fulfilment

Same-day Dubai dispatch
Next-day other emirates

Vial

AED 1,200

per vial

Popular

Vials

AED 3,300

AED 1,100/vial

Save AED 300

Best Value

Vials

AED 5,000

AED 1,000/vial

Save AED 1,000

In Stock — UAE · 2-4 Hour Delivery Across the UAE

GLP-1 — Satiety

Activates hypothalamic appetite centres to promote satiety signalling. The same receptor targeted by semaglutide, but combined with two additional agonists for triple-pathway activation.

GIP — Insulin

Enhances glucose-dependent insulin secretion and improves beta-cell function. The metabolic layer absent from single-agonist compounds like semaglutide.

Glucagon — Expenditure

Increases hepatic energy expenditure, promotes lipolysis, and enhances thermogenesis. The unique third pathway that differentiates retatrutide from all other compounds.

40mg — Large Format

Lyophilized 40mg vial suits larger laboratory research workflows requiring custom reconstitution ratios. Bacteriostatic water required (not included).

FAQ

Retatrutide 40mg FAQ

What is retatrutide?

Retatrutide (LY3437943) is a synthetic triple-agonist research peptide developed by Eli Lilly that simultaneously activates GLP-1, GIP, and glucagon receptors. It is the first compound to target all three metabolic pathways in a single molecule. CAS: 2381089-83-2.

What is the purity?

Our ProPeptide line ships under the same cold-chain and research-use protocols as our Janoshik-verified flagship. Batch-specific COA documentation will be added to our public COA library as it becomes available.

What is the price in AED?

AED 1,200 per vial (single), AED 3,300 for a 3-pack (AED 1,100/vial), and AED 5,000 for a 5-pack (AED 1,000/vial). Same-day Dubai delivery on all orders.

How is it shipped?

Each 40mg lyophilized vial is dispatched under 2–8°C cold-chain from our Dubai facility. Same-day Dubai dispatch when ordered before 4 PM; other emirates dispatch next day when ordered before 12 PM. Order finalized on WhatsApp. Bacteriostatic water is required for reconstitution and is not included.

Is it for research use only?

Yes. ProPeptide Retatrutide 40mg is sold strictly for in-vitro laboratory research under UAE MoHAP Circular 17/2022. It is not approved for human therapeutic use, veterinary use, or consumption. See our UAE research peptide compliance guide for full detail.

Order Retatrutide 40mg — Dubai & UAE

40mg lyophilized vial • Triple-agonist LY3437943 • From AED 1,000/vial • Same-day Dubai delivery • WhatsApp confirmation in minutes.

Order Now →

More research compounds

Also in our catalog

Other research peptides available with Dubai cold-chain delivery.

ProPeptide Retatrutide 10mg

10mg lyophilized vial · triple-agonist LY3437943 · cold-chain dispatch

ProPeptide Tirzepatide 10mg

10mg lyophilized vial · dual-agonist LY3298176 · cold-chain dispatch